Free Trial

Procter & Gamble Company (The) $PG Shares Bought by Martin Capital Partners LLC

Procter & Gamble logo with Consumer Staples background

Key Points

  • Martin Capital Partners LLC increased its stake in Procter & Gamble by 209.7% in the second quarter, owning 35,942 shares valued at approximately $5.7 million.
  • CEO Sundar G. Raman sold 9,554 shares for over $1.5 million, reducing his position by 18.57%.
  • Procter & Gamble's stock had a 0.4% decline, with a recent opening price of $158.02 and an average target price of $175.12 from analysts.
  • Five stocks we like better than Procter & Gamble.

Martin Capital Partners LLC grew its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 209.7% during the second quarter, according to its most recent Form 13F filing with the SEC. The firm owned 35,942 shares of the company's stock after purchasing an additional 24,335 shares during the period. Procter & Gamble makes up approximately 2.2% of Martin Capital Partners LLC's investment portfolio, making the stock its 20th largest holding. Martin Capital Partners LLC's holdings in Procter & Gamble were worth $5,726,000 as of its most recent filing with the SEC.

Several other institutional investors have also bought and sold shares of the stock. D. Scott Neal Inc. grew its position in Procter & Gamble by 10.3% in the 2nd quarter. D. Scott Neal Inc. now owns 3,607 shares of the company's stock valued at $575,000 after buying an additional 338 shares in the last quarter. MRA Advisory Group raised its position in shares of Procter & Gamble by 69.2% during the 2nd quarter. MRA Advisory Group now owns 2,139 shares of the company's stock worth $341,000 after buying an additional 875 shares in the last quarter. Richard P Slaughter Associates Inc lifted its stake in shares of Procter & Gamble by 2.6% in the 2nd quarter. Richard P Slaughter Associates Inc now owns 5,937 shares of the company's stock worth $946,000 after acquiring an additional 148 shares during the period. Canandaigua National Bank & Trust Co. boosted its holdings in shares of Procter & Gamble by 2.2% in the second quarter. Canandaigua National Bank & Trust Co. now owns 81,525 shares of the company's stock valued at $12,989,000 after acquiring an additional 1,732 shares in the last quarter. Finally, RMR Wealth Builders increased its stake in shares of Procter & Gamble by 13.1% during the second quarter. RMR Wealth Builders now owns 16,325 shares of the company's stock valued at $2,601,000 after acquiring an additional 1,895 shares during the period. Institutional investors and hedge funds own 65.77% of the company's stock.

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, CEO Sundar G. Raman sold 9,554 shares of the firm's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,511,060.64. Following the completion of the sale, the chief executive officer owned 41,886 shares in the company, valued at approximately $6,624,689.76. This trade represents a 18.57% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Jennifer L. Davis sold 8,596 shares of Procter & Gamble stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,351,892.92. Following the sale, the chief executive officer owned 64,991 shares in the company, valued at $10,221,134.57. This represents a 11.68% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 120,181 shares of company stock worth $18,918,012. Insiders own 0.20% of the company's stock.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on PG shares. Barclays set a $164.00 target price on Procter & Gamble and gave the stock an "equal weight" rating in a research report on Thursday, July 31st. Wells Fargo & Company cut their price objective on Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating for the company in a report on Wednesday, July 30th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and set a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a report on Friday, July 25th. UBS Group set a $180.00 price target on shares of Procter & Gamble and gave the company a "buy" rating in a report on Wednesday, July 30th. Finally, Evercore ISI reaffirmed an "in-line" rating and issued a $170.00 price objective (down previously from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. One analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and seven have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $175.12.

Get Our Latest Analysis on Procter & Gamble

Procter & Gamble Stock Down 0.4%

Procter & Gamble stock opened at $158.02 on Monday. The firm's 50 day moving average price is $156.21 and its two-hundred day moving average price is $161.77. The firm has a market cap of $369.85 billion, a PE ratio of 24.27, a P/E/G ratio of 4.17 and a beta of 0.36. Procter & Gamble Company has a twelve month low of $149.91 and a twelve month high of $180.43. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70.

Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The firm had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. The company's revenue for the quarter was up 1.7% on a year-over-year basis. During the same quarter last year, the firm earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. On average, research analysts predict that Procter & Gamble Company will post 6.91 EPS for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a dividend of $1.0568 per share. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's dividend payout ratio is presently 64.82%.

Procter & Gamble Company Profile

(Free Report)

Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.

Featured Articles

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Procter & Gamble Right Now?

Before you consider Procter & Gamble, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.

While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Markets Brace for Fed: What Investors Need to Know Before Wednesday
3 Biotech Stocks Under $5 With Huge Upside
Revealed: Congress’ Biggest Stock Moves This Month

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines